https://www.avient.com/sites/default/files/2021-11/artisan-ar7300-pre-colored-formulation-processing-guide.pdf
HDPE is not recommended for purging
as it can cause delamination or lead to black specks.
Runners
• Full-round runners or modified trapezoid runners are the best designs.
• Half-round runners are not recommended.
• Only naturally balanced runner systems (“H” pattern) are recommended.
• Runner diameters should not be less than the part thickness.
• Runner diameter should be 1.5x the part thickness.
• Step each 90° bend in the system down in size.
• Place vents at each 90° intersection and vent to atmosphere.
• Hot runner molds are acceptable and should be sized by the manufacturer.
Sink Marks
Melt too hot
• Decrease nozzle and barrel temperatures
• Decrease mold temperature
Insufficient
material volume
• Adjust transfer position
• Increase shot size
• Increase injection rate
• Increase packing pressure
Part geometry
too thick
• Reduce wall thickness
• Reduce rib thickness
TROUBLESHOOTING RECOMMENDATIONS
PROBLEM CAUSE SOLUTION
Flash
Injection pressure
too high
• Decrease injection pressure
• Increase clamp pressure
• Decrease injection rate
• Increase transfer position
Excess
material volume
• Adjust transfer position
• Decrease pack pressure
• Decrease shot size
• Decrease injection rate
Melt and/or mold
temperature too hot
• Decrease nozzle and barrel temperatures
• Decrease mold temperature
Loose clamp
• Reset mold height
• Increase clamp tonnage
Shrink
Too much shrink
• Increase cooling time
• Decrease mold temperature
Too little shrink
• Decrease cooling time
• Increase mold temperature
Burning
Process related
• Decrease nozzle and barrel temperatures
• Decrease mold temperature
• Decrease injection rate
• Reduce decompression
Mold design
• Clean, widen and increase number of vents
• Increase gate size to reduce shear
Wet material • Verify material is dried at proper condition
Nozzle Drool
Nozzle temperature
too hot
• Decrease nozzle temperature
• Decrease back pressure
• Increase screw decompression
• Verify material has been dried at proper conditions
Incorrect nozzle • Use reverse taper tip
Weld Lines
Melt front
temperatures are
too low
• Increase injection rate
• Increase pack and hold pressure
• Increase melt temperature
• Increase mold temperature
Mold design
• Increase gate size
• Identify end of fill pattern and verify proper
vent location
• Add vents or increase vent width
• Move gate location
TROUBLESHOOTING RECOMMENDATIONS
PROBLEM CAUSE SOLUTION
Warp
Process related
• Increase melt temperature
• Reduce injection speed
• Increase pack pressure
• Increase pack time
• Decrease mold temperature
• Increase cool time
Mold design • Non-uniform mold cooling
Part design • Non-uniform wall thickness
Thermolator incorrect
temperature
• Check settings
• Inspect thermocouple
Sticking in Mold
Overfilled cavity
• Decrease injection rate and pressure
• Decrease hold pressure
• Adjust transfer position
• Decrease nozzle and barrel temperatures
• Decrease mold temperature
• Decrease cooling time
Part too hot
• Decrease barrel temperature
• Decrease mold temperature
• Increase cooling time
Mold design
• Increase draft angle
• Polish cores in direction of ejection
Black Specks
Contamination • Purge machine
Degradation
• Reduce melt temperature
• Reduce screw speed
• Reduce back pressure
Machine related • Check for wear on screw, barrel or check ring
Delamination
Process related
• Increase melt temperature
• Decrease injection speed
• Purge barrel to eliminate material contamination
Mold design
• Reduce sharp corners in material flow path
• Increase venting
TROUBLESHOOTING RECOMMENDATIONS
PROBLEM CAUSE SOLUTION
Discoloration
Oversheared material
• Decrease melt temperature
• Decrease injection speed
• Reduce residence time
Mold design • Increase gate sizing
Dry material
• Check moisture of material to ensure it is within the
recommended moisture percentage for molding
TROUBLESHOOTING RECOMMENDATIONS
1.844.4AVIENT
www.avient.com
Copyright © 2021, Avient Corporation.
https://www.avient.com/sites/default/files/2023-05/AVNT Q1 2023 Earnings Presentation.pdf
AVIENT CORPORATION
F I R S T Q U A R T E R 2 0 2 3 R E S U L T S
(NYSE: AVNT)
M A Y 3 , 2 0 2 3
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
2023E(%)
32
79
87
83 81
76
73
90
79 77 76
73
69
60
22
A
vi
e
n
t
K
W
R
P
P
G
F
U
L
A
V
Y
R
P
M
F
M
C
C
E
H
X
L
A
S
H
E
C
L
H
U
N
E
M
N
S
C
L
M U LT I P L E E X PA N S I O N
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
Source: Peer data per Bloomberg as of April 28, 2023
Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.51.
Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years.
33
EV / 2023E EBITDA
Historic Multiple
6.5
8.3
9.9
14.6
13.7
13.0
11.9
8.8
18.7
17.4
11.8
10.0 9.7
9.1
8.0 7.9
A
vi
e
n
t
(2
0
1
1
)
A
vi
e
n
t
(2
0
1
8
)
A
vi
e
n
t
(2
0
2
3
)
K
W
R
P
P
G
R
P
M
A
V
Y
F
U
L
E
C
L
H
X
L
F
M
C
A
S
H
S
C
L
C
E
E
M
N
H
U
N
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2022-04/Avient Acquisition of Dyneema and Q1 2022 Results_0.pdf
NYSE: AVNT)
AVIE NT CORP ORAT ION
S P E C I A L T Y P O R T F O L I O T R A N S F O R M A T I O N
C O N T I N U E S W I T H D Y N E E M A A C Q U I S I T I O N
2 0 2 2 F I R S T Q U A R T E R R E S U L T S
D I S C L A I M E R
2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Outdoor High Performance) 8 18% 3
Growth in Asia / LATAM 6 3% 2
Other 100 19% 5
Sub-total $1,327 14% $146
Outdoor High Performance Impact (5) (3)
Wage Inflation and Overtime (11)
Other Supply Chain Costs (4)
Synergies 5
Incentives, Other Employee Costs 8
FX (28) (5)
Q1 2022 $1,294 11% $136
Q1 2022 SALES AND OPERATING INCOME
( T O TA L C O M PA N Y )
6
Sales Growth Rate
Adjusted
Operating
Income$ millions
Adjusted
EBITDA
Q1 EBITDA BRIDGE
7
Price increases more than
offset raw material and
supply chain impacts
Q1 2021 $ 161
Demand (23)
$ millions
CAI:
Price / Mix 77
Inflation (54)
SEM:
Price / Mix 41
Inflation (26)
Distribution:
Price / Mix 84
Inflation (82)
Net Price Benefit 40
Wage Inflation and Overtime (11)
Other Supply Chain Costs (4)
Synergies 5
Incentives, Other Employee Costs 8
FX (5)
Q1 2022 $ 171
China Lockdowns / Russia Impact $ (7)
Transportation (7)
Outdoor High Performance (3)
Q1 EPS BRIDGE
8
Q1 2021 - Adjusted EPS 0.89$
CAI 0.08
Specialty Engineered Materials 0.06
Distribution 0.00
Corporate Costs 0.02
F/X (0.04)
Segment OI 0.12
Tax Rate (0.02)
Q1 2022 - Adjusted EPS 0.99$
10
15x stronger than steel
Reduces weight by 30% vs. other solutions
Well-maintained global asset base poised to serve growing demand
• Purchase price of $1.48B represents 11.4x multiple of
2022 EBITDA
• Acquisition will expand Avient’s composites and fiber
portfolio with Dyneema®, the World’s Strongest Fiber™
• $415M sales and 30%+ EBITDA margins; Immediately
accretive to pro forma 2022 EPS, adding $0.35
• 1,300 patents globally, ~50% of sales patent protected
• 1,000+ employees across global production network and
dedicated technology centers
• Composites platform will increase from $261M to $680M in
revenue and from $49M to $180M in EBITDA Indicates Dyneema
® location
$175M
(42%)
$65M
(16%)
$175M
(42%)
2022E Sales By Region ($M)
(1) $0.35 EPS excludes intangible amortization
(2) Based on 2022 expected results
(1) (2)
(2)
F I T W I T H F O U R P I L L A R S T R AT E G Y
11
Specialization
• Innovation-led organization with
tremendous intellectual property value in
trademarks, patents and “know-how”
• Deep history of application development
and premium, leading brand with the
World’s Strongest FiberTM
Globalization
• Global customer base with an
established presence across all major
geographic regions
• Global technology centers complement
existing Composites applications and
expertise
Operational
Excellence
• Best-in-class safety performance
• Well-run and maintained asset base fit to
serve future growth
• Highly effective and reliable supply chain
with emphasis on optimizing service to
customers
Commercial
Excellence
• Deep customer relationships extend
across the value chain and drive ability
to grow
• Offer a full suite of services with an active
role in design, development and
commercialization
People
Experienced and
talented associates
with a passion for
safety, specialization
and winning
DY N E E M A ® OV E RV I E W
K E Y I N D U S T R I E S
PERSONAL PROTECTION
Military • Law Enforcement • First
Responders Body Armor • Helmets •
Vehicle Protection
$215M
MARINE & SUSTAINABLE
INFRASTRUCTURE
Towing / Mooring • Aquaculture •
Floating Wind • Offshore Cranes
$130M
CONSUMER
Consumer • Outdoor High Performance •
Safety Equipment
$70M
12 Figures reflect 2022 expected sales
MIFOverview Competition
Value chain &
Go-to-market
Strategy Innovation Financials
TECHNOLOGY
13
1,200 1,300
2,500
Avient Dyneema Combined
Patents
• True specialty business – the World’s Strongest Fiber™
• Deep history of application development with customers,
strongest in the industry
• The only UHMwPE (ultra-high molecular weight polyethylene)
fiber producer that is backward integrated
o Provides innovation advantage through control of all steps of the process
• Complementary with our existing reinforced film expertise
(PolyStrand) and engineered fiber presences (Fiber-Line)
WINNING PROPERTIES
Ultra high strength vs. weight Highly flexible
Floats on water Chemically inert; no smell/taste and non-toxic
High resistance to UV radiation Self-lubricating, with low friction
One-of-a-kind technology
®
FORMULATION PROCESS
14
• Like Avient, Dyneema® offers similar
core competencies around formulation
and material science
• Technology that combines polymers and
fibers to provide specialized, high
performing solutions for customers
• Design capabilities ensure that
applications are highly customized for
the specified end use
DYNEEMA ® IN THE VALUE CHAIN
15
UHMwPE
Fiber / Tapes
Military Personnel,
Law Enforcement
Heavy Marine,
Offshore Wind Energy
and Mooring,
Aquaculture
Outdoor,
Footwear, Apparel,
Inflatables
• Material Science
• Formulation
• Service
INTERMEDIATE MANUFACTURING
(CUSTOMERS) OEM / APPLICATION
DEMAND TRENDS
16
• Military spending and near-term demand for higher performing personal protection
products (like Dyneema®) expected to increase
o European NATO members annual defense spend expected to increase by up to 20%(1)
o Accelerated launch of next generation technology in North America
• Policy-driven demand for sustainable energy; growth in floating offshore wind
farms which require advanced, durable technology
o Offshore wind expected to grow at a CAGR of 32% with the level of annual installations
quadrupling over the next five years(2)
• Continued investment in aquaculture as a sustainable food source(3)
• Strong demand in outdoor high performance space across niche consumer
applications aligns with 10% growth assumption for Avient’s Composites portfolio
Sources:
(1) “Funding NATO”, NATO.int (April 1, 2022)
(2) “Global Wind Report 2021”, Global Wind Energy Council
(3) “Aquaculture Supports a Sustainable Earth”, NOAA Fisheries
17
A L I G N M E N T W I T H
S U S T A I N A B I L I T Y G O A L S
P RO D U C T S
AVIE NT ’S E XIS T ING COM P OS IT E S P ORT F OL IO
D I V E R S E C A P A B I L I T I E S A N D S O L U T I O N S S E R V I N G
M A N U F A C T U R E R S A N D O E M S
LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers
18
AV I E N T ’ S C O M P O S I T E S P O RT F O L I O
S A L E S A N D E B I T DA
19
$74 $84
$216 $212
$261
$5 $10
$32
$41
$49
$180
0
50
100
150
200
$-
$50
$100
$150
$200
$250
$300
$350
$400
$450
$500
$550
$600
$650
$700
$750
2017 2018 2019 2020 2021 2022E
$680
($ in millions)
• Dyneema® acquisition will further
improve Composites EBITDA margins
to 26%
• Dyneema® will complement our
existing portfolio with deep formulation
expertise, innovative culture and
global commercial presence
• Composites will continue to be a key
growth driver to deliver future revenue
growth in excess of GDP
(1) Pro forma for the acquisition of Dyneema®
(1)
D I S T R I BU T I O N D I V E S T I T U R E
C O N S I D E R AT I O N S
D I S T R I BU T I O N H I G H L I G H T S
21
$21
$57
$69
$94
$105
0
50
100
150
2006 2011 2016 2021 2022E
• Leading North American Distribution business with
longstanding blue-chip supplier and customer
relationships
• Commercial excellence and regulatory knowledge have
grown healthcare portfolio to over 25% of sales and
positioned business for long-term growth
• Highly specialized portfolio of engineered polymers along
with sustainable solution offerings
• Leading digital capabilities through Avient Now, allowing
enhanced visibility and 24/7 interface with customers
• 98% free cash flow conversion drives greater than 30%
after-tax return on invested capital (ROIC)
• Potential divestiture allows us to remain modestly
leveraged with net debt to adjusted EBITDA expected to
be 2.9x and positions us for further specialty growth in the
future
EBITDA (in $M)
DY N E E M A ® T R A N S AC T I O N OV E RV I E W
22
- $1.48B net purchase price
- Represents 11.4x expected 2022 EBITDA
- Committed financing in place
- Permanent financing to be combination of available cash on-hand, new
Senior Unsecured Notes, new Senior Secured Term Loan
- Potential proceeds from Distribution divestment could be used to pay down
near-term maturing debt
- Closing expected in second half of 2022, subject to regulatory
approvals and certain customary closing conditions
Transaction
Value
Financing
Closing
Conditions /
Timing
C A P I TA L S T RU C T U R E / L E V E R AG E
23
• Financing commitments secured from Morgan Stanley
and J.P.
Purchase price multiple rapidly declining on strength of
business and synergy capture
(1)
(1)
(1) Financial information is pro forma to include a full year of Clariant Color acquisition
($ in millions)
11.9%
16.2%
2019PF 2021
EBITDA Margins
(1)
S P E C I A LT Y T R A N S F O R M AT I O N
7%
46%
66%
86%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2015 2021 2022 PF
%
o
f A
dj
us
te
d
E
B
IT
D
A
(1
)
JVs Distribution Performance Products & Solutions Specialty
(1) Adjusted EBITDA is EBITDA excluding corporate costs and special items
(2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution
(2)
29
12%
18%
16% 15% 15% 14% 14%
28% 28%
26%
25%
22% 21% 19%
16%
12%
9% 9%
A
vi
en
t T
od
ay
A
vi
en
t P
F
A
V
Y
P
P
G
K
W
R
FU
L
R
P
M C
E
A
LB
FM
C
A
S
H
E
C
L
E
M
N
H
X
L
H
U
N
S
C
L
B
N
R
U
N
V
R
Median: 21%Median: 15%
2 0 2 2 E B I T DA M A RG I N S V S .
https://www.avient.com/sites/default/files/2023-06/Trilliant HC-auto-injector-snapshot.pdf
M E D I C A L C O N T R AC T
M A N U FAC T U R E R
A U T O - I N J E C T O R H O U S I N G
• Excellent chemical and wear resistance
• Excellent impact resistance
• Specific color matching based on customer’s needs
• Outstanding durability to extend product life
• Customized a chemically resistant formulation
to offer an impact-modified alternative to
traditional competitors in the market
• Provided technical support for material
selection, part & tool design, and process
development to accelerate commercialization
• Delivered custom color matching to meet all
key requirements
Custom Trilliant™ HC Healthcare Thermoplastic
KEY REQUIREMENTS
WHY AVIENT?